In adult T-ALL, CDKN2A/B homozygous deletion (CDKN2A/Bhomo) was associated with a favorable prognosis only within the mature/cortical group (32), while other studies showed a correlation with poor survival or no association with outcome (31, 33). This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.